FPM welcomes new Chair of Rare Diseases Expert Group
Find out more
Posted on: Tuesday 8 July 2025
Author: FPM
As FPM prepared to leave it’s offices in Angel Gate in June 2025, we were honoured to welcome Paul Domenet for a special visit to the boardroom named after his father, Dr Jean-Georges (John) Domenet, who was FPM’s third President.
An FPM team comprising Dr Marcia Philbin (Chief Executive), Andrew Meads (Head of Operations), and Will Strange (Head of External Affairs) welcomed Paul on 25 June for an emotional visit during which he shared fascinating memories and insights about his father and wider family.
John Domenet was a founding figure in pharmaceutical medicine and played a pivotal role in the early development of FPM. After initially serving as Vice President, he assumed the Presidency after the incumbent, Denis Burley, died in office. He was subsequently elected to the post and served from 1992 – 1995.
You can read more about John Domenet in this obituary.